PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1391969
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1391969
Global automated cell counters market size is expected to be valued at US$ 3.75 Bn in 2023, and is expected to reach US$ 6.01 Bn by 2030, exhibiting a compound annual growth rate (CAGR) of 7.0% from 2023 to 2030.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2022 | Market Size in 2023: | US$ 3.75 Bn |
Historical Data for: | 2018 to 2021 | Forecast Period: | 2023 - 2030 |
Forecast Period 2023 to 2030 CAGR: | 7.00% | 2030 Value Projection: | US$ 6.01 Bn |
Automated cell counters are advanced laboratory instruments that are used for the accurate and efficient counting of cells in various biological samples. These instruments have revolutionized the field of cell analysis by providing quick and reliable results, and thus, eliminating the need for manual counting methods. The global market is witnessing significant growth due to increasing demand for cell-based research and rising prevalence of chronic diseases.
Global automated cell counters market is dominated by key players such as Thermo Fisher Scientific, Danaher Corporation, Agilent Technologies, PerkinElmer Inc., Bio-Rad Laboratories, BD, Merck KGaA, Logos Biosystems, Corning Incorporated, Tecan, and Sartorius AG. These companies are constantly investing in research and development activities to introduce innovative products and gain a competitive edge in the market.
Global automated cell counters market growth is driven increasing adoption of automated cell counting techniques in research and diagnostic laboratories. These instruments offer advantages such as high accuracy, reproducibility, and time efficiency, and this boosts their demand.
Growing prevalence of chronic diseases such as cancer and infectious diseases boosts demand for automated cell counters. These instruments play a crucial role in disease diagnosis, monitoring treatment response, and drug discovery, thereby, driving the market growth.
However, there are certain factors restraining the market growth. The high cost of automated cell counters and the need for skilled professionals to operate these instruments are hindering their widespread adoption, especially in developing regions. Moreover, the lack of awareness about the benefits of automated cell counting techniques among healthcare professionals is also impeding the market growth.
Nevertheless, the market is expected to witness significant opportunities in the near future. Increasing focus on personalized medicine and rising demand for cell-based therapies are expected to boost adoption of automated cell counters. Moreover, advancements in technology such as the integration of artificial intelligence and machine learning algorithms in these instruments are expected to further enhance their capabilities and expand their applications.